A method of treating abnormal angiogenesis via the BAI family of proteins and their protein fragments

Details for Australian Patent Application No. 2008265840 (hide)

Owner Emory University

Inventors Van Meir, Erwin

Agent Pizzeys

Pub. Number AU-A-2008265840

PCT Pub. Number WO2008/157572

Priority 60/936,196 19.06.07 US

Filing date 18 June 2008

Wipo publication date 24 December 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/157572 Priority application(s): WO2008/157572

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008265841-Method for inter-radio access technology cell reselection

2008265838-Device and method for restoration of the condition of blood